Patients also have to be at least 18 and able to understand that the treatment is experimental, said Dr. David Beckham, an associate professor in the infectious diseases division on the University of Colorado’s Anschutz Medical Campus. People who have had previous bad reactions to plasma therapies or who have a condition that make receiving more fluid dangerous, like a severe heart or kidney problem, might not qualify.